Clinical Edge

Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

Hydroxyurea tolerated well in sickle cell patients

Dauvergne B et al. FSCDR 2018 (annual meeting of the Foundation for Sickle Cell Disease Research), presentation JSCDH-D-18-00052.

Key clinical point: Hydroxyurea has been well tolerated by children and adults with sickle cell disease.

Major finding: Of adult participants, 16.9% have experienced hydroxyurea-related adverse events.

Study details: Observational 10-year study of 2,000 adults and children with SCD who were taking hydroxyurea.

Disclosures: The study was sponsored by Addmedica, which markets hydroxyurea as Siklos. Dr. Dauvergne is employed by Addmedica.

Source: Dauvergne B et al. FSCDR 2018 (annual meeting of the Foundation for Sickle Cell Disease Research), presentation JSCDH-D-18-00052.

Read the article.

Citation:

Dauvergne B et al. FSCDR 2018 (annual meeting of the Foundation for Sickle Cell Disease Research), presentation JSCDH-D-18-00052.

This Week's Must Reads

Phase 3 data on emicizumab, Mahlangu et al. N Engl J Med. 2018;379:811-22

Integrated programs ease sickle cell pain, hospitalizations, Annual meeting of the Foundation for Sickle Cell Disease Research

Watch for RBC adhesion in men with sickle cell , Annual meeting of the Foundation for Sickle Cell Disease Research

FDA approves Jivi for hemophilia A, Package insert, news release

Marzeptacog alfa demonstrates efficacy as prophylaxis in hemophilia, Levy H et al. 2018 Hemophilia Drug Development Summit

Must Reads in Anemia

Integrated programs ease sickle cell pain, hospitalizations, Annual meeting of the Foundation for Sickle Cell Disease Research

Fewer sickle cell crises with L-glutamine use, Niihara Y et al. N Engl J Med. 2018 Jul 19;379(3):226-35.

Observational study shows hydroxyurea well tolerated in sickle cell disease, Dauvergne B et al. FSCDR 2018, presentation JSCDH-D-18-00052

Hydroxyurea tolerated well in sickle cell patients, Dauvergne B et al. FSCDR 2018 (annual meeting of the Foundation for Sickle Cell Disease Research), presentation JSCDH-D-18-00052.

Sickle cell symptoms cause patients to miss work, Vendetti N et al. Presentation at Foundation for Sickle Cell Disease Research Annual Meeting, June 2018.